Diaphragm Dysfunction After COVID-19 as Determined by Dynamic Chest Radiography
DD-COVID-19
1 other identifier
observational
24
1 country
1
Brief Summary
Dynamic chest radiography (DCR) is a rapid and easily performed technique that captures real-time continuous images of the moving chest. COVID-19 has led to various complications and long-term effects, with dyspnea being a common symptom experienced by many patients. Studies conducted abroad have indicated that dyspnea following a new coronavirus infection can be attributed to diaphragm dysfunction. This study using DCR aims to describe diaphragm function in patients after coronavirus disease (COVID-19).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 10, 2023
CompletedFirst Submitted
Initial submission to the registry
December 14, 2023
CompletedFirst Posted
Study publicly available on registry
December 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2025
CompletedDecember 26, 2023
December 1, 2023
4 months
December 14, 2023
December 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
diaphragm assessment
observe the differences in dynamic chest X-ray measurements between patients with COVID-19 and normal people
5 months
Secondary Outcomes (1)
Correlation between lung function and DCR
5 months
Study Arms (2)
control
Healthy, age and sex matched controls
Long Covid
patients who experienced persistent respiratory symptoms four weeks after contracting COVID-19
Interventions
A recent technological advancement in this field is dynamic chest radiography (DCR), which is a low-dose imaging system capable of producing continuous moving images
Eligibility Criteria
The study will compare a group of adults (over 18 years) in the community who experience breathlessness as a result of long COVID with a control group of healthy volunteers who are matched in terms of age and sex.
You may qualify if:
- COVID-19 group:
- Voluntarily sign the informed consent form;
- Aged equal to or older than 18 years old, regardless of gender;
- Inpatients with COVID-19 who mainly complain of dyspnea, dyspnea If it persists or develops and lasts for more than 4 weeks after acute COVID-19, it is related to long COVID-19; (confirmed infection with COVID-19 through nucleic acid monitoring or hospital laboratory data);
- Lung function measurements have been completed during hospitalization due to diagnosis and treatment needs;
- Be able to cooperate in completing the dynamic chest X-ray (complete the positioning of the dynamic chest X-ray for 20 seconds, and breathe calmly and forcefully during this period; be able to hold breath for at least 7 seconds).
- Control group:
- Voluntarily sign the informed consent form;
- Aged equal to or older than 18 years old, regardless of gender;
- People from the health examination center, and the age, gender are matched in the COVID-19 group and have no previous acute or chronic cardiopulmonary disease, no abnormalities in previous lung physical examinations and lung imaging examinations, and no history of infectious diseases in the past month;
- Physical examination items are required People who are suitable for ordinary chest X-ray examination;
- Be able to cooperate in completing dynamic chest X-ray (complete dynamic chest X-ray positioning for 20 seconds, during which period, breathe calmly and forcefully, and be able to hold breath for at least 7 seconds).
You may not qualify if:
- COVID-19 group:
- Not suitable to participate in this study;
- Combined with serious life-threatening diseases, such as cardiovascular and cerebrovascular diseases, lung cancer, airway obstruction, etc.;
- Combined with pneumothorax, pulmonary insufficiency, chronic disease, interstitial disease, lung surgery history or recent planned surgery;
- Mental disorder and unable to cooperate with the operator;
- Pregnant or lactating women;
- Major radiation related to the research within 12 months before consent Exposure (participating in previous studies involving radiation exposure, the research dose is limited to 0.4mSv);
- No evidence of having been infected with the new coronavirus;
- Unable to cooperate in completing dynamic chest X-rays;
- Unable to complete lung function measurements;
- Control group:
- Not suitable to participate in this study;
- Patients with previous acute or chronic cardiopulmonary disease, previous lung physical examination, lung imaging examination abnormalities, within the past 1 month Have a history of infectious diseases;
- Mentally abnormal and unable to cooperate with the operator;
- Pregnant or lactating women;
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yudong
Guangzhou, Guangdong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liu Laiyu, professor
Nanfang Hospital, Southern Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 14, 2023
First Posted
December 19, 2023
Study Start
November 10, 2023
Primary Completion
March 10, 2024
Study Completion
March 10, 2025
Last Updated
December 26, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share